CRISNOEL CERVANTES: Open Payments
NPI 1043211840 · WHITING, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,667 in 146 payments from 19 companies in 2025. Trend: 2023 $2,669 · 2024 $2,393 · 2025 $2,667
Food & beverage: $2,667
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 19 | $587 |
| Lilly USA, LLC | 11 | $284 |
| ABBVIE INC. | 25 | $283 |
| Amgen Inc. | 15 | $199 |
| Novo Nordisk Inc | 13 | $196 |
| PFIZER INC. | 12 | $193 |
| Corcept Therapeutics | 9 | $142 |
| GlaxoSmithKline, LLC. | 8 | $134 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $114 |
| Otsuka America Pharmaceutical, Inc. | 4 | $85 |
Products named: AIRSUPRA, FARXIGA, BREZTRI, Korlym, VRAYLAR, ZEPBOUND, OTEZLA, TRELEGY ELLIPTA.
Industry payments across NJ — which companies pay providers there.
